About Us

Mylan is one of the world’s leading quality generics and specialty pharmaceutical companies. The company offers one of the industry’s broadest and highest quality product portfolios, which contains more than 900 separate products; a robust product pipeline; and a global commercial footprint serving customers in more than 140 countries and territories. Employing approximately 15,000 people, Mylan has attained leading positions in key international markets through its wide array of dosage forms and delivery systems, significant manufacturing capacity, global scale and a committed focus on quality and customer service.

Mylan also operates Matrix, the world's third largest manufacturer of active pharmaceutical ingredients and intermediates, making it one of only two global generic companies with a comprehensive, vertically integrated supply chain.

Dey L.P., Mylan’s fully integrated specialty business, provides the company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.

Established Market Leader Mylan holds leading positions in 13 of the most competitive generics markets across the globe.*
Australia (No. 1) Belgium (No. 2) France (No. 1) Holland (No. 5) Ireland (No. 4)	Italy (No. 3) Japan (No. 4)** Portugal (No. 1) New Zealand (No. 1) Scandinavia (No. 4)	Spain (No. 3) United Kingdom (No. 2) United States (No. 2)
* as of March 15, 2008 ** largest international company